Home/Pipeline/PRECISION‑GI™

PRECISION‑GI™

Gastrointestinal malignancies (pancreatic, liver, biliary, lymph nodes)

commercialFDA 510(k) cleared, launched in U.S.

Key Facts

Indication
Gastrointestinal malignancies (pancreatic, liver, biliary, lymph nodes)
Phase
commercial
Status
FDA 510(k) cleared, launched in U.S.
Company

About Limaca Medical

Automated EUS biopsy device delivering consistent, high‑quality tissue for precision oncology.

View full company profile

Therapeutic Areas